endanger
Senior health service figures raise concerns that roll out of new Alzheimer’s drugs could cost taxpayer £1 billion per year and endanger the lives of patients with the disease
Health
Sarah Carter
Two much-hyped Alzheimer’s drugs may never get NHS approval after an official report claimed they have ‘limited clinical benefit’. Senior health service ...
